These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

682 related items for PubMed ID: 8838483

  • 1. A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 micrograms and 30 micrograms ethinylestradiol.
    Winkler UH, Schindler AE, Endrikat J, Düsterberg B.
    Contraception; 1996 Feb; 53(2):75-84. PubMed ID: 8838483
    [Abstract] [Full Text] [Related]

  • 2. The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives.
    Norris LA, Bonnar J.
    Br J Obstet Gynaecol; 1996 Mar; 103(3):261-7. PubMed ID: 8630312
    [Abstract] [Full Text] [Related]

  • 3. Double-blind, randomized, placebo controlled study on the effects of the monophasic oral contraceptive containing 30 micrograms ethinyl estradiol and 2.00 mg dienogest on the hemostatic system.
    Spona J, Feichtinger W, Kindermann C, Schneider B, Mellinger U, Walter F, Moore C, Gräser T.
    Contraception; 1997 Aug; 56(2):67-75. PubMed ID: 9315414
    [Abstract] [Full Text] [Related]

  • 4. Studies on oral contraceptive-induced changes in blood coagulation and fibrinolysis and the estrogen effect on endothelial cells.
    Quehenberger P, Kapiotis S, Pärtan C, Schneider B, Wenzel R, Gaiger A, Speiser W.
    Ann Hematol; 1993 Jul; 67(1):33-6. PubMed ID: 8392873
    [Abstract] [Full Text] [Related]

  • 5. Effects of monophasic low-dose oral contraceptives on fibrin formation and resolution in young women.
    Petersen KR, Sidelmann J, Skouby SO, Jespersen J.
    Am J Obstet Gynecol; 1993 Jan; 168(1 Pt 1):32-8. PubMed ID: 8420344
    [Abstract] [Full Text] [Related]

  • 6. Multicenter trial of two monophasic oral contraceptives containing 30 mcg ethinylestradiol and either desogestrel or gestodene in Thai women.
    Koetsawang S, Charoenvisal C, Banharnsupawat L, Singhakovin S, Kaewsuk O, Punnahitanont S.
    Contraception; 1995 Apr; 51(4):225-9. PubMed ID: 7796587
    [Abstract] [Full Text] [Related]

  • 7. A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 30 micrograms ethinylestradiol/75 micrograms gestodene, with respect to efficacy, cycle control, and tolerance.
    Endrikat J, Müller U, Düsterberg B.
    Contraception; 1997 Mar; 55(3):131-7. PubMed ID: 9115000
    [Abstract] [Full Text] [Related]

  • 8. Haemostasis profile in smoking and nonsmoking women taking low-dose oral contraceptives.
    Fruzzetti F, Ricci C, Fioretti P.
    Contraception; 1994 Jun; 49(6):579-92. PubMed ID: 8070263
    [Abstract] [Full Text] [Related]

  • 9. [Hemostatic balance during treatment with the newest contraceptives].
    Petersen KR, Skouby SO, Sidelmann J, Jespersen J.
    Ugeskr Laeger; 1994 Jan 10; 156(2):187-90. PubMed ID: 8296409
    [Abstract] [Full Text] [Related]

  • 10. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A.
    Int J Fertil Menopausal Stud; 1995 Jan 10; 40 Suppl 2():98-104. PubMed ID: 8574257
    [Abstract] [Full Text] [Related]

  • 11. Hemostatic effects of two oral contraceptives containing low doses of ethinyl estradiol and either gestodene or norgestimate: an open, randomized, parallel-group study.
    Winkler UH, Oberhoff C, Bier U, Schindler AE, Gillain D.
    Int J Fertil Menopausal Stud; 1995 Jan 10; 40(5):260-8. PubMed ID: 8556031
    [Abstract] [Full Text] [Related]

  • 12. Effect of two oral contraceptives containing ethinylestradiol and gestodene or norgestimate upon androgen parameters and serum binding proteins.
    Wiegratz I, Jung-Hoffmann C, Kuhl H.
    Contraception; 1995 Jun 10; 51(6):341-6. PubMed ID: 7554973
    [Abstract] [Full Text] [Related]

  • 13. Hemostasis profile and lipid metabolism with long-interval use of a desogestrel-containing oral contraceptive.
    Cachrimanidou AC, Hellberg D, Nilsson S, von Schoulz B, Crona N, Siegbahn A.
    Contraception; 1994 Aug 10; 50(2):153-65. PubMed ID: 7956214
    [Abstract] [Full Text] [Related]

  • 14. Hemostatic effects of smoking and oral contraceptive use.
    Fruzzetti F.
    Am J Obstet Gynecol; 1999 Jun 10; 180(6 Pt 2):S369-74. PubMed ID: 10368523
    [Abstract] [Full Text] [Related]

  • 15. Clinical comparison of two low-dose oral contraceptives, Minulet and Mercilon, in women over 30 years of age.
    Kirkman RJ, Pedersen JH, Fioretti P, Roberts HE.
    Contraception; 1994 Jan 10; 49(1):33-46. PubMed ID: 8137624
    [Abstract] [Full Text] [Related]

  • 16. Effect of two low-dose gestodene containing monophasic oral contraceptives on hemostasis in Bulgarian women.
    Uchikova E, Pehlivanov B.
    Expert Opin Pharmacother; 2008 Aug 10; 9(11):1839-44. PubMed ID: 18627323
    [Abstract] [Full Text] [Related]

  • 17. Effect of levonorgestrel contraceptive implants, Norplant, on blood coagulation.
    Shaaban MM, Elwan SI, el-Kabsh MY, Farghaly SA, Thabet N.
    Contraception; 1984 Nov 10; 30(5):421-30. PubMed ID: 6440738
    [Abstract] [Full Text] [Related]

  • 18. Effect of two oral contraceptives containing ethinyl estradiol and gestodene or norgestimate on different lipid and lipoprotein parameters.
    Wiegratz I, Jung-Hoffmann C, Gross W, Kuhl H.
    Contraception; 1998 Aug 10; 58(2):83-91. PubMed ID: 9773262
    [Abstract] [Full Text] [Related]

  • 19. Ethinylestradiol 20 versus 30 micrograms combined with 150 micrograms desogestrel: a large comparative study of the effects of two low-dose oral contraceptives on the hemostatic system.
    Winkler UH, Hölscher T, Schulte H, Zierleyn JP, Collet W, Schindler AE.
    Gynecol Endocrinol; 1996 Aug 10; 10(4):265-71. PubMed ID: 8908527
    [Abstract] [Full Text] [Related]

  • 20. Influence of gestodene and desogestrel as components of low-dose oral contraceptives on the pharmacokinetics of ethinyl estradiol (EE2), on serum CBG and on urinary cortisol and 6 beta-hydroxycortisol.
    Hammerstein J, Daume E, Simon A, Winkler UH, Schindler AE, Back DJ, Ward S, Neiss A.
    Contraception; 1993 Mar 10; 47(3):263-81. PubMed ID: 8462317
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.